Results 21 to 30 of about 339 (90)

The anti-inflammatory and haemodynamic effects of levosimendan on advanced heart failure patients: a meta-analysis of published studies. [PDF]

J Int Med Res, 2023
Zhou S, Li D, Zhang L, Li J.
europepmc   +1 more source

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered. [PDF]

Cardiol J, 2021
Sanfilippo F, La Via L, Merola F, Astuto M.   +3 more
europepmc   +1 more source

Effect of intravenous levosimendan or milrinone on left atrial pressure in patients undergoing off-pump coronary artery bypass grafting-A prospective double-blind, randomized controlled trial. [PDF]

Ann Card Anaesth, 2023
Mondal A, Ghosh K, Kar SK, Dammalapati PK, Dasgupta CS.   +4 more
europepmc   +1 more source

Levosimendan in Cardiac Arrest (LeiCA): Protocol for a Randomized, Double-Blind, Phase II Clinical Trial. [PDF]

Acta Anaesthesiol Scand
Rysz S, Flam B, Hedberg M, Galmén K, Mårtensson J, Djärv T, Jonsson Fagerlund M.   +6 more
europepmc   +1 more source

Use of levosimendan in hemodynamic management of heart failure in two neonates with intracranial arteriovenous shunts: a case series. [PDF]

Ital J Pediatr, 2023
Landolfo F, Giliberti P, De Rose DU, Pugnaloni F, Santisi A, Columbo C, Martini L, Ronchetti MP, Di Chiara L, Toscano A, Gandolfo C, Dotta A, Capolupo I.   +12 more
europepmc   +1 more source

The potential effect of calcium sensitizer in pulmonary hypertension post-coronavirus disease-19 infection in presumptive familial dilated cardiomyopathy: a case report. [PDF]

J Med Case Rep
Andryan DP, Hasanah DY, Atmadikoesoemah CA.   +2 more
europepmc   +1 more source

Weaning from invasive ventilation with levosimendan (WEANLESS): study protocol for a multicentre randomised clinical trial. [PDF]

BMJ Open
De Leijer E, Hofma C, Serpa Neto A, Hunfeld NGM, Schultz MJ, Doorduin J, Heunks L.   +6 more
europepmc   +1 more source

Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. [PDF]

BMJ Open
Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL.   +5 more
europepmc   +1 more source

The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis. [PDF]

ESC Heart Fail
Nuzzi V, Madaudo C, Manca P, Cannata A, Raffa G, Mulè M, Cannata S, La Franca E, Pisano C, Cipriani M, Lorusso R.   +10 more
europepmc   +1 more source

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report. [PDF]

Cardiol J, 2022
Fox H, Gummert JF, Sommer P, Knabbe C, Sohns C.   +4 more
europepmc   +1 more source